Skip to main content
. 2019 Mar 8;13:201. doi: 10.3389/fnins.2019.00201

FIGURE 7.

FIGURE 7

Rosiglitazone increases Ucp2 transcription but does not alter glaucomatous RGC loss. (A) Microbead injection increases IOP to a similar extent in control- and rosiglitazone (RSG)-fed mice. (B) Intraperitoneal RSG increases Ucp2 transcript levels in the mouse retina. (C) Increased IOP leads to RGC loss (decreased % survival), though dietary RSG does not appear to alter RGC loss. (D) Representative RBPMS labeling in whole-mount retinas from PBS- and bead-injected C57BL6J mice. p < 0.05.